Detalles de la búsqueda
1.
Impact of Natural Killer Cell-Associated Factors on Acute Leukemia Outcomes after Haploidentical Hematopoietic Stem Cell Transplantation with αß T Cell Depletion in a Pediatric Cohort.
Transplant Cell Ther
; 30(4): 435.e1-435.e12, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38278183
2.
Targeted Therapy With Venetoclax and Daratumumab as Part of HSCT Preparative Regimen in Children With Chemorefractory Acute Myeloid Leukemia.
Transplant Cell Ther
; 29(2): 127.e1-127.e9, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36436779
3.
Post-Transplantation Immunosuppression After TCRΑß/CD19 Graft Depletion Does Not Improve HSCT Outcomes in Primary Immunodeficiency.
Transplant Cell Ther
; 28(3): 172.e1-172.e4, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34875404
4.
Serotherapy-Free Regimen Improves Non-Relapse Mortality and Immune Recovery Among the Recipients of αß TCell-Depleted Haploidentical Grafts: Retrospective Study in Childhood Leukemia.
Transplant Cell Ther
; 27(4): 330.e1-330.e9, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33836878
5.
T-cell tracking, safety, and effect of low-dose donor memory T-cell infusions after αß T cell-depleted hematopoietic stem cell transplantation.
Bone Marrow Transplant
; 56(4): 900-908, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33203952
6.
Safety and efficacy of the low-dose memory (CD45RA-depleted) donor lymphocyte infusion in recipients of αß T cell-depleted haploidentical grafts: results of a prospective randomized trial in high-risk childhood leukemia.
Bone Marrow Transplant
; 56(7): 1614-1624, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33594278
Resultados
1 -
6
de 6
1
Próxima >
>>